Detalles de la búsqueda
1.
Systemic antibiotics for Pseudomonas aeruginosa infection in outpatients with non-hospitalised exacerbations of pre-existing lung diseases: a randomised clinical trial.
Respir Res
; 25(1): 236, 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38844921
2.
Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.
Respir Res
; 22(1): 155, 2021 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34020641
3.
A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol.
BMC Pulm Med
; 17(1): 114, 2017 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28810909
4.
Vitamin D deficiency and airflow limitation in the Baltimore Longitudinal Study of Ageing.
Eur J Clin Invest
; 45(9): 955-63, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26173468
5.
Association between vitamin D status and COPD phenotypes.
Lung
; 192(4): 493-7, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24748443
6.
Prognostic value of C-reactive protein, leukocytes, and vitamin d in severe chronic obstructive pulmonary disease.
ScientificWorldJournal
; 2014: 140736, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24587707
7.
Validation of the i-BODE index as a predictor of hospitalization and mortality in patients with COPD participating in pulmonary rehabilitation.
COPD
; 11(4): 381-7, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24111845
8.
Inhaled corticosteroids and Stenotrophomonas maltophilia in outpatients with chronic obstructive pulmonary disease: a retrospective cohort study.
BMJ Open Respir Res
; 11(1)2024 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38460975
9.
Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-label trial.
Trials
; 23(1): 817, 2022 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36167555
10.
Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis.
Eur Clin Respir J
; 7(1): 1757274, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32489532
11.
Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Trials
; 21(1): 513, 2020 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32522282
12.
A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations.
ERJ Open Res
; 5(4)2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31754621
13.
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials.
ERJ Open Res
; 5(2)2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31111041
14.
Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial.
Lancet Respir Med
; 7(8): 699-709, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31122894
15.
[Treatment of stable chronic obstructive pulmonary disease].
Ugeskr Laeger
; 180(25)2018 Jun 18.
Artículo
en Da
| MEDLINE | ID: mdl-29938633
Resultados
1 -
15
de 15
1
Próxima >
>>